Latka logo
Entelexo Biotherapeutics logo

Entelexo Biotherapeutics

Irvine, California, United States

Valuation

$15M

2024 Revenue

$5M

Funding

$0

Team

3

Founded

2020

How Entelexo Biotherapeutics CEO MILAD RIAZIFAR grew Entelexo Biotherapeutics to $5M revenue with a 3 person team in 2024.

Creating a New Class of Drugs to Address Incurable Autoimmune Diseases

Last updated

Entelexo Biotherapeutics Revenue

In 2024, Entelexo Biotherapeutics's revenue reached $5M. Since its launch in 2020, Entelexo Biotherapeutics has shown consistent revenue growth.

Entelexo Biotherapeutics Revenue GrowthReported revenue / ARR by year$0$1M$3M$4M$5M$6M20202021202220232024$0$5MSource: GetLatka.com
YearMilestone
2024Entelexo Biotherapeutics Hit $5m revenue in June 2024
2020Launched with $0 revenue

Entelexo Biotherapeutics Valuation, Funding Rounds

Entelexo Biotherapeutics's most recent disclosed valuation is $15M.

Entelexo Biotherapeutics is a bootstrapped SaaS startup. Founded in 2020, Entelexo Biotherapeutics has grown to $5M in revenue without raising any venture capital or outside funding.

As a self-funded SaaS company, Entelexo Biotherapeutics has built its business with no outside investment.

Entelexo Biotherapeutics Capital Raised & ValuationCumulative capital raised and post-money valuation by roundCapital raised (cum.)Valuation$0$120202020 cumulative: $0 • 2020 Founded: $02020 Founded: $0 valuationSource: GetLatka.com
YearRoundAmountValuation% Sold

Entelexo Biotherapeutics Employees & Team Size

Entelexo Biotherapeutics employs approximately 3 people as of 2026.

Entelexo Biotherapeutics has 3 total employees in different roles and functions.

Entelexo Biotherapeutics Team GrowthReported headcount over time012234202020212022202320240033Source: GetLatka.com
YearMilestone
2024Reached 3 employees (June 2024)
2024Reached 3 employees (June 2024)

Founder / CEO

MILAD RIAZIFAR

MILAD RIAZIFAR is listed as Founder / CEO at Entelexo Biotherapeutics.

Q&A

QuestionAnswer
What's your age?-
Favorite online tool?-
Favorite book?-
Favorite CEO?-
Advice for 20 year old self-

Customers

We do not have customer count information for Entelexo Biotherapeutics yet.

Frequently Asked Questions about Entelexo Biotherapeutics

What is Entelexo Biotherapeutics's revenue?

Entelexo Biotherapeutics generates $5M in revenue.

Who founded Entelexo Biotherapeutics?

Entelexo Biotherapeutics was founded by MILAD RIAZIFAR.

Who is the CEO of Entelexo Biotherapeutics?

The CEO of Entelexo Biotherapeutics is MILAD RIAZIFAR.

How much funding does Entelexo Biotherapeutics have?

Entelexo Biotherapeutics raised $0.

How many employees does Entelexo Biotherapeutics have?

Entelexo Biotherapeutics has 3 employees.

Where is Entelexo Biotherapeutics headquarters?

Entelexo Biotherapeutics is headquartered in Irvine, California, United States.

People Also Viewed

treble.ai logo

treble.ai

Treble.ai is an internet based company.

Resend logo

Resend

Email for developers

LawRank logo

LawRank

SEO company for lawyers specializing in organic SEO, PPC and web design helping clients rank for competitive, high-traffic keywords

Echobox logo

Echobox

Developer of an artificial intelligence platform intended to help online publishers to share content on social media. The company's platform helps news publishers to maximize their reach on social media by detecting viral content and giving suggestions on which articles to share on social networks at specific times, enabling clients to increase sale and save time.

Graft logo

Graft

Graft is a cloud-native platform that empowers everyone in your organization to wield the most advanced AI techniques to unlock the value of text, images, video, audio, and graphs. No machine learning skills required, no team to hire, and no infrastructure to build or maintain.

Spider AF - Digital Ad Fraud Prevention logo

Spider AF - Digital Ad Fraud Prevention

Spider AF is an ad fraud detection tool that detects, blocks, and protects web ads from invalid clicks and conversions. With centralized fraud management and advanced automation, advertisers can easily detect fraudulent activity across published ads. Spider AF provides full digital advertising transparency, allowing advertisers to track ad placement, identify fraudulent behaviors, and analyze clean - fraud free data. With Spider AF, advertisers can view in-depth transparent reports that assist advertisers with making the right ad campaign decisions. Spider AF can stop suspicious users and bots in advance, and protect the advertising content and marketing analysis of any business. Advertisers can easily install Spider AF within a matter of minutes. Just add the Spider AF measurement tag to your website and start analyzing activity. Experience optimal ad performance without the fraud with Spider AF. Visit our website for more details and start preventing ad fraud with our one month free trial!

Source Attribution

Source: all data was collected from GetLatka company research and founder interviews. Revenue, funding, team, and customer figures are presented as company-reported or GetLatka-estimated metrics where the profile data identifies them that way.

Company data last updated .

Entelexo Biotherapeutics Revenue 2024: $5M ARR